Analysts Set Intuitive Surgical, Inc. (NASDAQ:ISRG) PT at $554.17

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have been given a consensus recommendation of “Moderate Buy” by the nineteen research firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and fifteen have given a buy recommendation to the company. The average 1 year target price among brokers that have covered the stock in the last year is $554.17.

A number of brokerages recently issued reports on ISRG. Royal Bank of Canada raised their price target on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Truist Financial lifted their target price on Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, December 18th. Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, December 11th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Finally, Leerink Partners upped their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th.

Insider Transactions at Intuitive Surgical

In related news, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares in the company, valued at $12,391,166.97. The trade was a 42.84 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,788,899.12. This trade represents a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 48,190 shares of company stock valued at $25,012,927 in the last 90 days. Insiders own 0.90% of the company’s stock.

Institutional Trading of Intuitive Surgical

Large investors have recently bought and sold shares of the stock. Godsey & Gibb Inc. lifted its stake in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the period. LGT Financial Advisors LLC lifted its position in Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 54 shares during the period. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical during the 3rd quarter valued at about $33,000. Mark Sheptoff Financial Planning LLC purchased a new stake in Intuitive Surgical during the 2nd quarter valued at about $37,000. Finally, Capital Performance Advisors LLP acquired a new position in shares of Intuitive Surgical in the third quarter valued at about $38,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 2.3 %

Intuitive Surgical stock opened at $544.02 on Thursday. Intuitive Surgical has a 12-month low of $325.77 and a 12-month high of $556.23. The firm has a 50-day moving average price of $534.30 and a 200-day moving average price of $493.26. The firm has a market capitalization of $193.77 billion, a PE ratio of 87.46, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. As a group, sell-side analysts predict that Intuitive Surgical will post 5.45 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.